About Tony Hsu
Form D filings for SEngine Precision Medicine in 2023 list Tony Hsu as executive officer.
Tony Hsu first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Tony Hsu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tony Hsu works with at each company, as listed on that company's latest Form D.
SEngine Precision Medicine, Inc. · Form D, Mar 10, 2023
CK
Christopher Kemp
Executive officer and promoter
PP
Pablo Prichard
Director
EB
Elliott Burkland
Director
CG
Carla Grandori
President and CEO, director